Recent studies show that NKG2A forms a crucial checkpoint for controlling T cell and NK cell activation in cancerous conditions.24,26 The checkpoint receptors mediate the delivery of multiple signals, the balance of which determines if NK cells kill their target cells, such as stressed cells and tumor cells, or remain inactive.27–29. The gene discussed is KLRC1; the disease is neoplasm.